The Summit will bring Canada’s most promising health science companies to Niagara-on-the-Lake to present to and meet with global investors.

Highlighting companies across three fast-growing sectors:

  1. New Frontiers in Medicine, including regenerative medicine, rare diseases, therapeutics, and medical devices

  2. Artificial Intelligence in Health

  3. Digital Health and Diagnostics

With world-class technologies and a great environment for investment, Canadian companies present an incredible opportunity for global health science investors and we are looking forward to bringing the world to Canada’s doorstep.
— Gail Garland, President and CEO, OBIO



OBIO 2019 Niagara Investment Summit Eligibility

  • Companies based in Canada focused on developing health science products or services including but not limited to therapeutics, medical devices, diagnostics, or digital health which fit into the themes of the 2019 Niagara Investment Summit.

  • Companies based in Canada seeking to raise Series A and beyond investment.

Companies selected to participate in the 2019 Niagara Investment Summit will be on a rolling basis and presentation spots are limited. Interested companies should send an email to Christina Yeh ( and include a non-confidential pitch deck (15 slides maximum), demonstrating how your company fits within the theme of the Summit.



OBIO 2019 Niagara Investment Summit Participation cost

Selected companies are responsible for the conference fee of $2,500 which includes:

  • Full registration for one company representative

  • An opportunity to pitch and hold one-on-one meetings with leading global investors

  • Attendance at a health science CEO roundtable dinner discussion

  • Two nights’ accommodation

  • Breakfast, lunch and dinner for the duration of the conference